Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
L-lysine is an essential alpha-amino acid that humans must obtain through diet to support protein biosynthesis and various metabolic functions [PubChem CID 5962]. It is a critical component for the structural integrity of connective tissues, as it is required for the cross-linking of collagen polypeptides through the action of lysyl oxidase [NIH MedlinePlus]. Additionally, lysine acts as a precursor to carnitine, facilitating the transport of long-chain fatty acids into the mitochondria for beta-oxidation and energy production [PubChem CID 5962]. Clinically, lysine is most notable for its role as a dietary supplement used to prevent or treat Herpes Simplex Virus (HSV) infections; its mechanism involves competing with arginine—a required nutrient for HSV replication—thereby potentially reducing viral load and outbreak frequency [StatPearls, PubMed PMID 664366]. While lysine is not a traditional therapeutic macromolecular target (such as an enzyme or GPCR), it is central to the pathology of metabolic conditions like hyperlysinemia and is investigated for its potential to improve calcium absorption and mitigate anxiety [National Organization for Rare Disorders, Mayo Clinic]. In pharmaceutical manufacturing, lysine is frequently utilized as a counter-ion to improve the solubility and pharmacokinetic profiles of various drug formulations, such as ibuprofen lysine [NCBI].
L-lysine acts as a competitive antagonist of L-arginine for cellular transport and incorporation into viral proteins, thereby inhibiting the replication of arginine-dependent viruses like Herpes Simplex Virus [StatPearls, PubMed PMID 664366]. It also serves as a fundamental substrate for protein synthesis, collagen cross-linking, and carnitine biosynthesis [PubChem CID 5962].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on L-lysine (Lys).